AI Article Synopsis
- The American Association of Bronchology and Interventional Pulmonology aims to keep clinicians informed with brief, current reviews on essential interventional pulmonology topics, starting with malignant pleural disease.
- The article consists of three parts that update readers on malignant pleural effusion: diagnosis through imaging and fluid biomarkers, management strategies including multimodal approaches and targeted therapies, and details on pleural mesothelioma.
- These reviews are part of the Essential Knowledge series presented at the 2023 AABIP Annual Conference, and recorded lectures are available for access on the AABIP website.
Article Abstract
The goal of the American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series is to provide clinicians with concise, up-to-date reviews of important topics in the field of interventional pulmonology. This 3-year alternating rotation of primary topics will start with a focus on selected topics in malignant pleural disease. In this article, we update the reader on malignant pleural effusion in 3 parts: part 1-diagnosis, focusing on imaging and fluid biomarkers; part 2-management, with review of multimodal approaches, cost considerations, and evolving targeted therapies; and part 3-pleural mesothelioma. These reviews complement the Essential Knowledge in Interventional Pulmonology Lecture Series presented at the 2023 AABIP Annual Conference, available for viewing on the AABIP website (https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/LBR.0000000000000999 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!